These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21262586)

  • 1. Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions.
    Kurokawa M; Sato S
    J Biosci Bioeng; 2011 May; 111(5):600-4. PubMed ID: 21262586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
    Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
    Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
    Wu SC; Liu CC; Lian WC
    Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus.
    Wu SC; Huang GY
    Biotechnol Prog; 2002; 18(1):124-8. PubMed ID: 11822910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.
    Mattos DA; Silva MV; Gaspar LP; Castilho LR
    Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    Dev Biol Stand; 1981; 47():41-53. PubMed ID: 6262160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor.
    Toriniwa H; Komiya T
    Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
    Sanders BP; Edo-Matas D; Custers JH; Koldijk MH; Klaren V; Turk M; Luitjens A; Bakker WA; Uytdehaag F; Goudsmit J; Lewis JA; Schuitemaker H
    Vaccine; 2013 Jan; 31(5):850-6. PubMed ID: 23123018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model of adherent Vero cell growth and poliovirus production in animal component free medium.
    Ursache RV; Thomassen YE; van Eikenhorst G; Verheijen PJ; Bakker WA
    Bioprocess Biosyst Eng; 2015 Mar; 38(3):543-55. PubMed ID: 25294335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses.
    Cinatl J; Cinatl J; Rabenau H; Rapp J; Kornhuber B; Doerr HW
    Cell Biol Int; 1993 Sep; 17(9):885-95. PubMed ID: 8220316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.
    Montagnon B; Vincent-Falquet JC; Fanget B
    Dev Biol Stand; 1983; 55():37-42. PubMed ID: 6677539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.
    Berry JM; Barnabé N; Coombs KM; Butler M
    Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier.
    Wang D; Xiao C; Chen Z; Huang Z
    Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.
    Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA
    Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.